Niagen Bioscience CEO Rob Fried explains nicotinamide riboside (NR), energy, and new at-home injections, IVs, and NAD+ ...
CEO Rob Fried reveals Niagen Bioscience’s NAD+ growth strategy, from Tru Niagen to their upcoming telehealth launch.
Settle down in a comfy chair with some of the week’s best longreads.
What are peptides?!' This thought might pop into your head if you take even the quickest scroll through the top beauty trends ...
© 2026 Forbes Media LLC. All Rights Reserved.
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
© 2026 Forbes Media LLC. All Rights Reserved.
NAD+ has become one of the most discussed topics in the longevity and performance space. Once limited to niche wellness circles, it is now being packaged into broader telehealth programs that promise ...